NCT06837012View on ClinicalTrials.gov

Duloxetine As an Analgesic in Patients Without Central Sensitivity After Same Sitting Bilateral Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL

Enrollment

106

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

July 31, 2022

Study Completion Date

July 31, 2022

Conditions

Osteoarthritis of KneeCentral SensitizationCentral Sensitisation

Interventions

DRUG

Duloxetine - low dose

Only patients who underwent single bilateral Total knee arthroplasty and WITHOUT central sensitisation were evaluated

DRUG

Placebo

starch capsules identical in appearance and weight to the duloxetine capsules

Trial Locations (1)

400007

Orthopaedic Arthroscopy Knee and shoulder clinic, Mumbai

All Listed Sponsors

collaborator

The Grant Medical College & Sir J.J. Group of Hospitals

OTHER_GOV

lead

Orthopaedic Arthroscopy Knee and Shoulder Clinic

OTHER

NCT06837012 - Duloxetine As an Analgesic in Patients Without Central Sensitivity After Same Sitting Bilateral Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter